✦ LIBER ✦

Pharmacokinetics of rituximab associated with CHOP chemotherapy in B-cell non-Hodgkin lymphoma

✍ Scribed by Hélène Blasco; Etienne Chatelut; Isabelle Benz De Bretagne; Nicolas Congy-Jolivet; Chantal Le Guellec

Book ID: 111194626
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 182 KB
Volume: 23
Category: Article
ISSN: 0767-3981
DOI: 10.1111/j.1472-8206.2009.00714.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Successful rituximab-CHOP treatment of s

Successful rituximab-CHOP treatment of systemic lupus erythematosus associated with diffuse large B-cell non-Hodgkin lymphoma

✍ Zs. Simon; T. Tarr; Zs. Ress; L. Gergely; E. Kiss; A. Illes 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 271 KB

Rituximab + CHOP beneficial in elderly w

Rituximab + CHOP beneficial in elderly with B-cell lymphoma

📂 Article 📅 2005 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

CHOP Chemotherapy plus Rituximab Compare

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

✍ Coiffier, Bertrand; Lepage, Eric; Brière, Josette; Herbrecht, Raoul; Tilly, Herv 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 116 KB

CHOP Chemotherapy plus Rituximab Compare

CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

✍ Coiffier, Bertrand; Lepage, Eric; Brière, Josette; Herbrecht, Raoul; Tilly, Herv 📂 Article 📅 2002 🏛 Massachusetts Medical Society 🌐 English ⚖ 116 KB

## Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP). Rituximab, a chimeric monoclonal antibody against the CD20 B-cell antigen, has therapeutic activity in diffuse large-B-cell lymphoma. We conduct

Clinical experience with biweekly CHOP p

Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma

✍ David Aguiar Bujanda; José Aguiar Morales; Uriel Bohn Sarmiento; Salvador Saura 📂 Article 📅 2009 🏛 Springer Milan 🌐 Spanish ⚖ 282 KB

Immune reconstitution of B-cell lymphoma

Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab

✍ Toshiro Kurokawa; Makiko Hase; Naoko Tokuman; Takashi Yoshida 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract Sixty‐six B‐cell lymphoma patients were treated with a CHOP‐based chemotherapy containing rituximab (R‐CHOP‐like regimen). Immune reconstitution was assessed by measuring lymphocyte subsets and immunoglobulins. Fifty‐five patients (83.3%) underwent six cycles of the R‐CHOP‐like regimen.